Skip to content

Bausch Health Companies BHC Free cash flow yield

Free cash flow yield at other companies

PBH
Prestige Consumer HealthcarePBH
8.8%+3.1pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.9%+1.7pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp
AbbVie logo
AbbVieABBV
5.2%+1.0pp
Organon logo
OrganonOGN
43.8%+23.6pp
HRO
HarrowHROW
1.2%+1.0pp

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Calculated from Bausch Health Companies’s reported figures.

Based on trailing twelve months.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's free cash flow yield?
Bausch Health Companies (BHC) reported free cash flow yield of 51.4% in Q1 2026.
How has Bausch Health Companies's free cash flow yield changed year-over-year?
Bausch Health Companies's free cash flow yield decreased by 0.3% year-over-year, from 51.5% to 51.4%.
What is the long-term trend for Bausch Health Companies's free cash flow yield?
Over 4 years (2020 to 2025), Bausch Health Companies's free cash flow yield has grown at a 38.4% compound annual growth rate (CAGR), from 10.6% to 39%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.